Liu Da, Lin Zhongying, Huang Ying, Qiu Min
Department of Orthopedics, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China.
Department of Ultrasound, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China.
Arch Biochem Biophys. 2022 Apr 15;719:109134. doi: 10.1016/j.abb.2022.109134. Epub 2022 Jan 24.
Osteoporosis is a common complication accompanied by spinal cord injury (SCI) occurrence. MicroRNAs (miRNAs) have been proved to play a crucial role in the progression of osteoporosis, but their regulating mechanism is unclear. The present study investigated miRNA-19b-3p level in SCI rats induced by modified Allen method, as well as the role of miRNA-19b-3p in osteogenic differentiation of bone marrow-derived mesenchymal stem cells (BMSCs). MiRNA-19b-3p expression and bone mineral density (BMD) of femurs were measured at day 21 and day 60 after SCI in rats. Obvious miRNA-19b-3p up-regulation and aggravated bone loss were observed. MiRNA-19b-3p overexpression suppressed BMSC-derived osteoblast differentiation, which was confirmed by the decrease in alkaline phosphatase (ALP) activity, EBF2 expression, osteoprotegrin (OPG) to receptor activator of nuclear factor kappa-B ligand (RANKL) ratio and cell mineralization degree. Besides, MiRNA-19b-3p knockdown could reverse this phenomenon. Dual-luciferase reporter assays verified the targeting relationship between miRNA-19b-3p and EBF2. The in vivo experiments confirmed miRNA-19b-3p down-regulation could significantly attenuate osteoporosis after SCI, which was verified by increased BMD, collagen content, femur mineralization degree, EBF2 protein, and OPG-to-RANKL ratio. The results show that miRNA-19b-3p plays an important role in the osteoporosis process after SCI through regulating EBF2 expression.
骨质疏松症是脊髓损伤(SCI)常见的并发症。微小RNA(miRNA)已被证明在骨质疏松症的进展中起关键作用,但其调控机制尚不清楚。本研究调查了改良Allen法诱导的SCI大鼠中miRNA-19b-3p的水平,以及miRNA-19b-3p在骨髓间充质干细胞(BMSC)成骨分化中的作用。在大鼠SCI后第21天和第60天测量股骨的miRNA-19b-3p表达和骨密度(BMD)。观察到明显的miRNA-19b-3p上调和骨质流失加重。miRNA-19b-3p过表达抑制了BMSC来源的成骨细胞分化,碱性磷酸酶(ALP)活性、EBF2表达、骨保护素(OPG)与核因子κB受体活化因子配体(RANKL)的比值以及细胞矿化程度的降低证实了这一点。此外,miRNA-19b-3p敲低可逆转这种现象。双荧光素酶报告基因检测验证了miRNA-19b-3p与EBF2之间的靶向关系。体内实验证实,miRNA-19b-3p下调可显著减轻SCI后的骨质疏松症,这通过增加BMD、胶原蛋白含量、股骨矿化程度、EBF2蛋白以及OPG与RANKL的比值得到验证。结果表明,miRNA-19b-3p通过调节EBF2表达在SCI后的骨质疏松症过程中起重要作用。